Cargando…
Inter- and intrafraction dose variations in robotic stereotactic body radiation therapy (SBRT) for perihilar cholangiocarcinoma in the prospective phase I STRONG trial
Using fiducial-marker-based robotic respiratory tumor tracking, we treated perihilar cholangiocarcinoma patients in the STRONG trial with 15 daily fractions of 4 Gy. For each of the included patients, in-room diagnostic-quality repeat CTs (rCT) were acquired pre- and post-dose delivery in 6 treatmen...
Autores principales: | Paronetto, Chiara, den Toom, Wilhelm, Milder, Maaike T. W., van Norden, Yvette, Baak, Rogier, Heijmen, Ben J. M., Méndez Romero, Alejandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032458/ https://www.ncbi.nlm.nih.gov/pubmed/36969072 http://dx.doi.org/10.3389/fonc.2023.1114737 |
Ejemplares similares
-
Stereotactic Body Radiation Therapy after Chemotherapy for Unresectable Perihilar Cholangiocarcinoma: The STRONG Trial, a Phase I Safety and Feasibility Study
por: Baak, Rogier, et al.
Publicado: (2021) -
Largely reduced OAR doses, and planning and delivery times for challenging robotic SBRT cases, obtained with a novel optimizer
por: Giżyńska, Marta K., et al.
Publicado: (2021) -
Protocol for the STRONG trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma, a phase I feasibility study
por: Koedijk, Merel S, et al.
Publicado: (2018) -
Impact of Using Unedited CT-Based DIR-Propagated Autocontours on Online ART for Pancreatic SBRT
por: Magallon-Baro, Alba, et al.
Publicado: (2022) -
Stereotactic Body Radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma
por: Mahadevan, Anand, et al.
Publicado: (2015)